Literature DB >> 26664316

Transient Cardiomyopathy and Quadriplegia Induced by Ephedrine Decongestant.

David F Snipelisky, Andrew K Kurklinsky, Razvan Chirila.   

Abstract

Ephedrine decongestant products are widely used. Common side effects include palpitations, nervousness, and headache. More severe adverse reactions include cardiomyopathy and vasospasm. We report the case of an otherwise healthy 37-year-old woman who presented with acute-onset quadriplegia and heart failure. She had a normal chest radiograph on admission, but developed marked pulmonary edema and bilateral effusions the next day. Echocardiography revealed a left ventricular ejection fraction of 0.18 and no obvious intrinsic pathologic condition such as foramen narrowing on spinal imaging. Laboratory screening was positive for methamphetamines in the urine, and the patient admitted to having used, over the past several weeks, multiple ephedrine-containing products for allergy-symptom relief. She was ultimately diagnosed with an acute catecholamine-induced cardiomyopathy and spinal artery vasospasm consequential to excessive use of decongestants. Her symptoms resolved completely with supportive care and appropriate heart-failure management. An echocardiogram 2 weeks after admission showed improvement of the left ventricular ejection fraction to 0.33. Ten months after the event, the patient was entirely asymptomatic and showed further improvement of her ejection fraction to 0.45. To our knowledge, ours is the first report of spinal artery vasospasm resulting in quadriplegia in a human being after ephedrine ingestion.

Entities:  

Keywords:  Cardiomyopathies/chemically induced; catecholamines; central nervous system stimulants/adverse effects; ephedra/adverse effects; heart failure/chemically induced; plant preparations/adverse effects; quadriplegia; sympathomimetics; vasoconstrictor agents/adverse effects

Mesh:

Substances:

Year:  2015        PMID: 26664316      PMCID: PMC4665290          DOI: 10.14503/THIJ-14-4487

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  8 in total

1.  Reversible catecholamine-induced cardiomyopathy by subcutaneous injections of epinephrine solution in an anesthetized patient.

Authors:  Y Sato; M Tanaka; T Nishikawa
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

2.  Catecholamine-induced cardiomyopathy and pheochromocytoma.

Authors:  Kay B Leissner; Feroze Mahmood; Jayashri R Aragam; Abolhassan Amouzgar; Rafael Ortega
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

3.  Cardiomyopathy associated with ephedra-containing nutritional supplements.

Authors:  Avneet Singh; Angampally G Rajeev; Mary L Dohrmann
Journal:  Congest Heart Fail       Date:  2008 Mar-Apr

4.  Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall.

Authors:  J F Alksne; J H Greenhoot
Journal:  J Neurosurg       Date:  1974-10       Impact factor: 5.115

5.  Catecholamine-induced vasoconstriction is sensitive to carbonic anhydrase I activation.

Authors:  I Puscas; M Coltau; L Gilau; R Pasca; G Domuta; M Baican; A Hecht
Journal:  Braz J Med Biol Res       Date:  2001-03       Impact factor: 2.590

6.  Plasma catecholamine concentrations associated with cerebral vasospasm.

Authors:  A B Loach; C R Benedict
Journal:  J Neurol Sci       Date:  1980-03       Impact factor: 3.181

7.  Ephedra-associated cardiomyopathy.

Authors:  Sarjita D Naik; Ronald S Freudenberger
Journal:  Ann Pharmacother       Date:  2004-01-23       Impact factor: 3.154

Review 8.  Initial presentation of pheochromocytoma with Takotsubo cardiomyopathy: a brief review of literature.

Authors:  Karthik R Gujja; Ahmed F Aslam; Vladimir Privman; Furqan Tejani; Balendu Vasavada
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-01       Impact factor: 2.160

  8 in total
  2 in total

1.  Cardiomyopathy Related to a Weight Loss Supplement: A Case Report and Review of Literature.

Authors:  Ghulam Murtaza; Sujeen Adhikari; Irfan Siddiqui; Hannah Lu; Aneesh Kuruvilla
Journal:  J Investig Med High Impact Case Rep       Date:  2017-06-02

2.  Methylephedrine-induced heart failure in a habitual user of paediatric cough syrup: a case report.

Authors:  Moeko Suzuki; Haruhiko Higashi; Shuntaro Ikeda; Osamu Yamaguchi
Journal:  Eur Heart J Case Rep       Date:  2020-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.